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SUMMARY
Trials in which treatments induce clustering of observations in one of two treatment arms, such as when
comparing group therapy with pharmacological treatment or with a waiting-list group, are examined
with respect to the efficiency loss caused by varying cluster sizes. When observations are (approxi-
mately) normally distributed, treatment effects can be estimated and tested through linear mixed model
analysis. For maximum likelihood estimation, the asymptotic relative efficiency of unequal versus equal
cluster sizes is derived. In an extensive Monte Carlo simulation for small sample sizes, the asymptotic
relative efficiency turns out to be accurate for the treatment effect, but less accurate for the random
intercept variance. For the treatment effect, the efficiency loss due to varying cluster sizes rarely exceeds
10 per cent, which can be regained by recruiting 11 per cent more clusters for one arm and 11
per cent more persons for the other. For the intercept variance the loss can be 16 per cent, which requires
recruiting 19 per cent more clusters for one arm, with no additional recruitment of subjects for the other
arm. Copyright q 2009 John Wiley & Sons, Ltd.
KEY WORDS: asymptotic relative efficiency; clustering effects of treatments; individually randomized
group treatment; sample size; varying cluster sizes
1. INTRODUCTION
Many study designs evaluating the effect of an intervention are characterized by observations being
correlated within clusters. This may arise in group or cluster randomized trials [1, 2], where groups
are assigned to one of several treatment conditions. Examples are cities with all of its citizens being
assigned to a prevention program or not, or patients nested within general practices being assigned
to one of several medication treatments. Groups in these cases are the units of assignment.
∗Correspondence to: Math J. J. M. Candel, Department of Methodology and Statistics, Maastricht University,
P.O. Box 616, 6200 MD Maastricht, The Netherlands.
†E-mail: Math.Candel@Stat.unimaas.nl
Received 12 July 2008
Copyright q 2009 John Wiley & Sons, Ltd. Accepted 2 April 2009
2308 M. J. J. M. CANDEL AND G. J. P. VAN BREUKELEN
Clustering of observations may also arise when individuals instead of groups are the units of
assignment. This is the case when the treatment itself induces clustering such as when treatments
are given to groups of individuals [3–5]. These designs are known as individually randomized
group treatment trials [6]. In such designs, interactions between persons within a group may lead
to the observations on the outcome variable being correlated. The clustering may occur in only
one of the treatment arms, such as when group therapy is compared with a condition involving
only medication (e.g. [7–9]) or when group therapy is compared with a condition not involving
any kind of intervention (e.g. [5, 10–12]).
Clustering effects due to treatment may also occur if the treatment is not given to a group as a
whole but on an individual basis. If several patients are treated by the same therapist, then patients
will be treated in a more similar way than patients treated by different therapists. Such therapist
effects may also lead to correlated observations within clusters [6, 13]. In addition, in this case
clustering may occur in only one of two treatment arms, such as when a comparison is made with a
waiting-list condition (e.g. [14–16]) or with a pharmacological or a placebo condition (e.g. [17]).
In the present study we will consider designs with treatment-induced clustering in one of two
treatment arms. Formulas for calculating the sample size for such designs have been derived by
Moerbeek and Wong [18] and Roberts and Roberts [4]. The present study extends these studies
by examining unequal cluster sizes. Unequal cluster sizes may be due to variation in actual cluster
size, but also due to non-response or dropout of subjects and therefore is quite common. We will
examine the efficiency loss for estimating the treatment effect due to variation of cluster size.
We assume that the data within each condition are (approximately) normally distributed and are
analyzed with linear mixed models. The efficiency loss will be derived for the asymptotic case,
when estimating the treatment effect through maximum likelihood (ML), and it will be checked
for finite samples by an extensive Monte Carlo simulation study. The issue is how much power is
lost and how to compensate for this loss.
The number of clusters as encountered in relevant studies as well as the size of the clusters
themselves are small (e.g. [4, 6, 8, 12, 19, 20]). The Monte Carlo study will therefore examine the
accuracy of the asymptotic efficiency loss for small sample sizes. The accuracy will be examined
for both ML and restricted ML estimation.
Although the primary interest is usually in the treatment effect, the variance of the random
effects in the linear mixed model may also be of interest. The treatment may be more successful
for some clusters than for others. Variations between clusters in the treatment effect may be due to
differences in the interactions between the clusters’ members or due to the influence of therapists
assigned to clusters. For the model under consideration, the random effects reflect such variations
between clusters in the effectiveness of the treatment. The variance of the random effects can be
used to construct prediction intervals for these cluster-specific treatment effects [21, 22]. We will
therefore also examine the efficiency loss due to varying cluster sizes when estimating the variance
of the random effects.
More complicated clustering is possible, such as when a condition with group therapy is
compared with a condition without any intervention, and instead of individuals, mental health
centres are assigned to the treatment arms. In these cases there may be clustering at two levels
within one arm (persons being nested within therapy groups, which in turn are nested within
mental health centres), and clustering at one level within the other arm (persons being nested
within mental health centres). Then compared with the design that we consider in this paper, there
is one additional level of clustering in each arm. Such clustering will not be considered in the
present study.
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The structure of the paper is as follows. Section 2 presents the linear mixed effects model for
trials comparing a condition with clustering to a condition without clustering. Section 3 provides
explicit expressions for the asymptotic relative efficiency (RE) of the estimator of the treatment
effect and of the random intercept variance in such designs. Section 4 discusses the design and
results of a Monte Carlo simulation that examines the RE of unequal versus equal cluster sizes for
various cluster size distributions with realistic cluster sizes. Section 5 illustrates how the results
of the present study can be used in planning a trial. The paper closes with some implications for
the planning phase of trials as well as some issues for further research.
2. SPECIFICATION OF THE LINEAR MIXED EFFECTS MODEL
In the condition with clustering, called the cluster condition in what follows, we have K clusters
(e.g. K therapy groups). In cluster j ( j =1, . . . ,K ) there are n j persons and the total number of
persons in the cluster condition is N =∑Kj=1 n j . In the other treatment condition, henceforth called
the control condition, there are no clusters of correlated observations, and the number of persons
in this K +1th cluster is nK+1. In the case of equal cluster sizes, we have n j =n for j =1, . . . ,K ,
but in general not for j =K +1 (e.g. when nK+1=N ). The dependent variable is a quantitative
outcome, denoted as yi j for person i in cluster j ( j=1, . . . ,K +1). If in each condition yi j is
(approximately) normally distributed, the linear mixed effects model is an adequate tool for data
analysis. The corresponding analysis model is then as follows (cf. [4, 5, 18]):
yi j =0+(1+u0 j +εi j )Inti j +i j (1−Inti j ) (1)
where Inti j denotes the treatment condition for person i in cluster j , and is coded as 1 for persons
in the cluster condition and 0 for persons in the control condition. With this coding scheme,
0 represents the mean score of the condition without clusters and 1 represents the treatment
effect (such as the treatment effect of group therapy versus pharmacological treatment). The terms
εi j and u0 j represent a random person and random cluster effect in the cluster condition, which
are assumed to be independently normally distributed with variances 2ε and 
2
0, respectively.
The random effect for persons in the control condition, i j , is also independently normally
distributed with a possibly different variance 2. Thus, the model has five unknown parameters





. The model parameters can be estimated through ML [22].
Commonly the parameter 1, representing the treatment effect averaged across all clusters, is the
parameter of primary interest. In case persons are randomly assigned to clusters (e.g. as in group
therapy), we can consider 1+u0 j as the treatment effect for cluster j (=1, . . . ,K ). Since u0 j is
normally distributed, 95 per cent of these cluster-specific treatment effects will be between the
boundaries 1−1.960 and 1+1.960 [21, 22]. This interval has been denoted as the predictive
interval for the cluster effects (not to be confused with the confidence interval for the treatment
effect 1) [21]. Hence, for expressing the variation in effectiveness of the treatment across clusters
by a predictive interval, the random intercept variance 20 is also a parameter of interest.
A relevant concept is the intraclass correlation. This is the correlation between the outcome
measures for two randomly drawn persons from the same cluster, and thus measures the depen-
dency among observations taken on members within the same cluster. For the treatment arm
with clustering, the intraclass correlation is: =20/(20+2ε). The larger the cluster variance as
Copyright q 2009 John Wiley & Sons, Ltd. Statist. Med. 2009; 28:2307–2324
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compared with the person variance in the cluster condition, the larger the intraclass correlation.
The correlation for two randomly drawn persons from two different clusters in this treatment arm is
zero. This treatment arm thus consists of clusters of correlated observations. For any two randomly
chosen persons in the other treatment arm, there is no correlation between outcome measures.
3. ASYMPTOTIC RE
We are interested in the estimator of the treatment effect, 1, and will also consider the estimator
of 20. For both parameters we will derive an expression for the asymptotic RE of the ML estimator
when comparing equal with unequal cluster sizes. Let Var(̂1|) and Var(̂20|) denote the variance
of the estimator of 1 and 
2
0, respectively, given a design . Let equal denote the design of a
study with equal cluster sizes, and let unequal denote a design with unequal cluster sizes. The RE
of unequal versus equal cluster sizes for the estimator of the treatment effect, RE(̂1), and for the








When ̂1 in equation (2) is the ML estimator, we can derive an expression for the RE. Let n̄
denote the average cluster size of the K clusters in the cluster condition and let w j be defined
as w j =(20+2ε/n j )−1. For equal cluster sizes, we have n j = n̄ for j =1, . . . ,K , and the weight
w j is denoted as we. Furthermore, let =2/2ε be the ratio of the error variance in the control
condition and the error variance in the cluster condition. The expression for the RE is as follows





































The RE for ̂1 depends on the ratio of the number of persons in the control condition versus the
number of persons in the cluster condition, nK+1/(nK ), which we will denote as the allocation
ratio. It also depends on the ratio of the error variance in the control condition versus the error
variance in the cluster condition . The following properties hold for RE(̂1), when keeping both
the allocation ratio and  constant:
1. The RE does not depend on the number of clusters K , but does depend on the intraclass
correlation  and the distribution of cluster sizes.
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2. When we multiply each n j by a factor c>0, and multiply (1−)/ by the same factor, this
does not affect the RE. As a consequence, the minimum of the RE will not depend on n, but
will only be achieved at a different value of  for each possible n. Note that the standard
deviation of cluster sizes changes by a factor c, whereas the minimum RE remains the same.
In examining the effect of cluster size variation on the minimum RE, we will therefore use
the coefficient of variation (CV), which divides the standard deviation of cluster sizes by the
average cluster size.
3. When →0 or →1, we have RE→1. For 0<<1, we can show that the RE<1 (as a
result of the Jensen inequality; see [23, p. 72]), implying that equal cluster sizes are optimal.
The RE for ̂1 in equation (3) is larger than
∑K
j=1w j/(Kwe), and decreases as  decreases
(while keeping  constant) and as the allocation ratio nK+1/(nK ) increases (while keeping K and
n constant). This implies that, for fixed , as →0 and for fixed K and n, as nK+1/(nK ) →∞,
the RE will approach its minimum,
∑K
j=1w j/(Kwe). The latter is the RE for the ML estimator
of the treatment effect in cluster randomized trials [24]. Thus asymptotically, the loss of efficiency
is equal to or smaller than the loss of efficiency for cluster randomized trials. The explanation is
that, since there is no clustering in one of the treatment arms, the variation in cluster sizes will
only affect the statistical information in one treatment arm. As the allocation ratio increases or 
decreases, Var(̂1) will be dominated more by the sampling variance in the cluster condition and
so equation (3) approaches the RE for cluster randomized trials.









































The relative efficiency RE(̂20) also satisfies property 1 and 2 of RE(̂1). Property 3 does not
hold, in that, when →0, RE(̂20) may become larger than 1 (as will also be seen later on, in the
Monte Carlo simulation study). When →1,RE→1. That asymptotic REs may become larger
than 1 for the variance component estimators, was also found for cluster randomized trials and
multicentre trials [25]. Furthermore, when studying the RE for these designs through a Monte
Carlo simulation study for small sample sizes, the simulated REs also exceeded 1 [26]. Note that
RE(̂20) (see equation (4)) does not depend either on the allocation ratio or on the ratio of error
variances, . Its expression is the same as that for cluster randomized trials [26].
4. MONTE CARLO INVESTIGATION OF THE RE
Through an extensive Monte Carlo simulation study, we will examine to what extent the asymptotic
results on RE hold for numbers of clusters and cluster sizes that are representative of realistic
sample sizes. The conditions of the simulation study are similar to those of Candel et al. [26].
However, in the context of comparing group with individual treatments, the number of clusters as
Copyright q 2009 John Wiley & Sons, Ltd. Statist. Med. 2009; 28:2307–2324
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Table I. Overview of the conditions of the Monte Carlo simulation.
Factor Levels
Distribution of cluster sizes∗ Unimodal, uniform, bimodal, positively
skewed, negatively skewed distribution
Average cluster size† 6, 10
Number of clusters 12
Intraclass correlation =0.01 up to 0.30, with steps of 0.01
Ratio of size of control versus cluster condition 0.25, 1, 4
Ratio of error variance in control versus cluster condition =0.5,1,2
Estimation method ML, REML
∗More details on the different cluster size distributions are given in Table II.
†A larger average cluster size of 10 was considered to be able to examine a larger range of cluster sizes.
well as the cluster sizes are typically smaller (e.g. [4, 6, 8, 12, 19]). This is also true for clinical
trials where clustering is induced by the therapist (e.g. [14, 17, 20]). For these smaller samples, it
will be useful to examine the accuracy of the asymptotic RE.
4.1. Design of the simulation study
In the simulation study the intercept 0 was set at 50 and the effect parameter 1 was set at 5. Since
the variance of the effect estimator (see equation (A8)) as well as the variance of the estimator of
the intercept variance (see equation (B1)) are asymptotically independent of the fixed regression
weights, this could be done without loss of generality. The following factors were systematically
varied in the simulation study: (1) the frequency distribution of the cluster sizes, (2) the average
cluster size n, (3) the size of the intraclass correlation , (4) the ratio of the error variances , (5)
the allocation ratio nK+1/(nK ) and (6) the estimation method. Table I displays the choices made
for these factors, the motivation is given in what follows.
4.1.1. Frequency distribution. Five different cluster size distributions were studied: (1) a unimodal,
(2) a uniform, (3) a bimodal, (4) a positively skewed and (5) a negatively skewed distribution.
Three different cluster sizes, ga,gb,gc, with respective frequencies fa, fb and fc were employed.
Details of the cluster size distributions can be found in Table II.
4.1.2. Average cluster size. For the cluster condition we chose an average cluster size n= 6, with a
range of 4. For symmetrical distributions this implies that the smallest n=4 and the largest n=8.
Since larger ranges of cluster sizes are not realistic for such n, a larger average cluster size of
n=10, was also examined to allow a range of cluster sizes as large as 12. These average cluster
sizes are representative of cluster sizes commonly encountered in trials comparing group with
individual interventions (e.g. [4–10, 12, 19, 27]), and in trials with therapist-induced clustering in
one of the treatments arms (e.g. [13, 15, 17, 20]).
The number of clusters was fixed at K =12. This is the representative of the number of clusters
that is needed for designs with equal cluster sizes to have sufficient power [18]. As was shown
in Section 3, RE(̂1) (holding  and the allocation ratio constant) does not depend on K , and
choosing a larger n gives the same RE at a smaller value of the intraclass correlation . However,
K and n were deliberately chosen to be small to check the accuracy of the asymptotic REs.
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Table II. Distributions of the cluster sizes in the cluster condition as examined in the
Monte Carlo simulation.
Cluster sizes
Coefficient of variation (CV)
Distribution∗,† ga gb gc Range of cluster sizes of cluster sizes
Unimodal 4 10 16 12 0.42
( fa =3, fb=6, fc=3) 4 6 8 4 0.24
Uniform 4 10 16 12 0.49
( fa =4, fb=4, fc=4) 4 6 8 4 0.27
Bimodal 4 10 16 12 0.55
( fa =5, fb=2, fc=5) 4 6 8 4 0.30
Positively skewed 7 10 19 12 0.42
( fa =6, fb=4, fc=2) 5 6 9 4 0.23
Negatively skewed 4 10 12 8 0.28
( fa =2, fb=4, fc=6) 3 6 7 4 0.24
∗ fa =number of clusters of size ga (small), fb=number of clusters of size gb (medium), fc=number of
clusters of size gc (large).
†Cluster sizes and cluster frequencies are chosen such that the total number of clusters in the cluster condition
is equal to K =12, the average cluster size n=6 or 10, and the ranges of the cluster sizes (=gc−ga) vary
between 12 and 4.
4.1.3. Intraclass correlation. The intercept variance 20 was set equal to values ranging from
1 to 30, with the error variance in the cluster condition 2ε simultaneously varying from 99 to 70,
to keep the total variance in the cluster condition at 100. As a result, the intraclass correlation in
the cluster condition, , ranged by steps of size 0.01 from 0.01 to 0.30, which represents the range
of intraclass correlations that are commonly encountered in cross-sectional studies [28, 29].
4.1.4. Ratio of error variances. The expression for RE(̂1) depends on the ratio of the error
variances,  (see equation (3)). Several studies indicate that this ratio varies between 1 and 2
[4, 8, 30]. In the present study these two values will be examined. Since RE(̂1) increases as a
function of , we will also consider =0.5 to obtain a pessimistic estimate of the efficiency loss
in this case.
4.1.5. The allocation ratio. The expression for RE(̂1) also depends on the allocation ratio,
nK+1/(nK ) (see equation (3)). In several studies the allocation ratio appeared to vary between 1.5
and 0.40 [7–10, 12, 14–16, 19, 27, 30, 31]. As shown by Moerbeek and Wong [18], when assuming
equal costs for subjects in the cluster condition and the control condition, and equal cluster sizes,
the optimal allocation ratio varies between 1 and 0.33. If costs of subjects in the cluster condition
are larger, the optimal allocation ratio is larger. We will therefore consider nK+1/(nK )=4,1 and
0.25 to cover the range of values that may be representative of realistic studies.
4.1.6. Estimation method. Initially four different likelihood-based estimation methods were
considered: ML estimation and restricted maximum likelihood (REML) estimation, combined
with either truncation of negative estimates of the variance components to 0, or without such
truncation. Since non-truncation in a substantial number of cases led to non-convergence and also
(when convergence was obtained) yielded very extreme values for the parameter estimates, only
the truncated estimators were examined further.
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Figure 1. Relative efficiency of the treatment effect estimator for a unimodal and bimodal distribution
of cluster sizes, with n=10,gc−ga =12,=0.5 and allocation ratio equal to 4. Displayed is also the
asymptotic relative efficiency of the ML estimator.
4.2. Simulation procedure
For each of the 2700 simulation conditions 10 000 data sets were generated, each representing the
data for 12 clusters consisting, on the average, of 6 or 10 persons. The control condition included
either 18, 30, 72, 120, 288 or 480 persons depending on the combination of the average cluster
size in the cluster condition and the allocation ratio. The simulations as well as the estimation of
the model parameters were performed using version 1.10.0007 of MLwiN [32]. To obtain ML and
REML estimates of the parameters, the estimation algorithms ‘Iterative Generalized Least Squares’
and ‘Restricted Iterative Generalized Least Squares’ were employed, respectively. In estimating
the model parameters, the convergence criterion was set to 0.001 and the number of iterations
was not limited. Based on the obtained estimates for the treatment effect and the random intercept
variance, the REs in equation (2) were calculated.
4.3. Results for the treatment effect
Figure 1 shows the simulated RE for ̂1 in case n=10 and, since we are interested in the minimum
values for the RE, for nK+1/(nK )=4 and =0.5. Cluster size distributions that give extreme
results in terms of RE are shown: the unimodal and the bimodal distribution. Since the ML and
REML estimators have comparable REs, only the results for REML are shown. Figure 1 shows
that the asymptotic RE and the simulated RE are rather close. In line with the asymptotic RE,
the simulated RE never exceeds 1. This implies that unequal cluster sizes are less efficient than
equal cluster sizes. For all distributions with n=10 and range of cluster sizes equal to 12, the RE
exceeded 0.92 (the minimum RE for the skewed distributions even exceeded 0.95), except for the
bimodal distribution, where the minimum RE approaches 0.90 (see Table III).
When n=6, the REs are larger, RE0.97 (see Table III), since the CV of cluster sizes is smaller.
For a uniform distribution and =1, Figure 2 illustrates that the RE indeed depends upon the
allocation ratio as predicted by the asymptotic RE. The more people are assigned to the control
condition, the lower the RE becomes. For the same cluster size distribution and an allocation
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Table III. Overview of the minimum relative efficiency based on the Monte Carlo simu-
lations, specified for the unimodal, uniform and bimodal distribution of cluster sizes. The
allocation ratio nK+1/(nK )=4 and =0.5.∗
Features of the cluster size distribution K =12, n=10, range=12 K =12, n=6, range=4
Bimodal Uniform Unimodal Bimodal Uniform Unimodal
Efficiency criterion CV=0.55 CV=0.49 CV=0.42 CV=0.30 CV=0.27 CV=0.24
Var(̂1) 0.90 0.92 0.94 0.97 0.97 0.98
Var(̂20) 0.84 0.86 0.87 0.92 0.92 0.95
*The allocation ratio nK+1/(nK )=4 and =0.5 were chosen, since these yield the lowest values for the RE
in terms of Var(̂1). For the RE in terms of Var(̂
2
0) this choice was irrelevant.
Figure 2. Relative efficiency of the treatment effect estimator for a uniform distribution of cluster sizes,
with n=6,gc−ga =4,=1 and allocation ratio equal to 14 or 4. Displayed is also the asymptotic relative
efficiency of the ML estimator.
ratio=1, Figure 3 shows that the higher the error variance in the control condition compared with
the error variance in the cluster condition, the higher the RE, also in line with the asymptotic
results.
Figures 2 and 3 furthermore demonstrate that also for n=6 and a uniform distribution of
cluster sizes the asymptotic RE and the simulated RE are close. The simulated RE seems to be
better approximated by the asymptotic RE, the smaller the CV of the cluster sizes, as illustrated
by Figures 1, 2 and 3. The uniform distributions with CV=0.27 show better approximations
(Figures 2 and 3) than the unimodal distribution with CV=0.42 (Figure 1). The unimodal distri-
bution in turn shows a better approximation than a bimodal distribution with CV=0.55 (Figure 1).
With increasing CV, the asymptotic RE first shifts from somewhat underestimating the simulated
RE to overestimating it, and then increasingly overestimates the simulated RE.
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Figure 3. Relative efficiency of the treatment effect estimator for a uniform distribution of cluster sizes,
with n=6,gc−ga =4,=0.5 or 2 and an allocation ratio of 1. Displayed is also the asymptotic relative
efficiency of the ML estimator.
Figure 4. Relative efficiency of the intercept variance estimator for a unimodal and bimodal distribution
of cluster sizes, with n=10,gc−ga =12,=0.5 and allocation ratio equal to 4. Displayed is also the
asymptotic relative efficiency of the ML estimator.
4.4. Results for the random intercept variance
As illustrated in Figure 4, the RE for 20, in line with the asymptotic results, may become larger
than 1 for small intraclass correlations. When estimating the intercept variance, unequal cluster
sizes may thus be more efficient. It can also be seen that the simulated RE, particularly in the case
of a bimodal distribution and REML, is not very accurately described by the asymptotic RE (for
small intraclass correlations, the discrepancy may be larger than 10 per cent). Furthermore, the RE
has a lower minimum than the RE for the treatment effect estimator. For the bimodal distribution
and n=10, the RE may become as low as 0.84 (see Figure 4), but for the other distributions
it always exceeds 0.86 (see Table III). For skewed distributions, the minimum REs were higher
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than 0.91. Again, when n=6, the REs are larger, RE0.92 (see Table III), since the CV is smaller.
As illustrated by Figure 4, for the random intercept variance the ML estimator has a higher RE
than the REML estimator.
5. APPLICATION IN PLANNING A TRIAL
When planning a trial in which there is clustering in one of the treatment arms, the results can
be used as follows. Let RE denote the relative efficiency of unequal versus equal cluster sizes.
Examining equation (A8) in Appendix A shows that there is only one practical way of restoring the
efficiency loss when estimating the treatment effect, which is multiplying the number of persons
in the control condition as well as the number of clusters in the cluster condition by a factor 1/RE.
It can be shown that it is not the optimal choice but very close to optimal. Optimal here means
minimizing the costs involved in a study, for a given precision of estimation.
We will first present a cost function for the design. Let cc be the costs attached to the persons
in the cluster condition, and let ci be the costs involved with persons in the control condition.
Furthermore, let cg be the extra costs attached to each of the groups in the cluster condition. The
total costs of the design, C , can then be defined as:
C=nK+1ci +nKcc+Kcg (5)
This cost function can also be used if one is interested in minimizing the total number of persons,
that is nK+1+nK , simply by setting cc=ci =1 and cg =0 in equation (5). Since often there
is an ideal group size for the cluster condition, we may consider n fixed, and we can rewrite
equation (5) as:
C=nK+1ci +K (ncc+cg)=nK+1ci +Kc∗c (6)
To compensate for the efficiency loss due to unequal cluster sizes in the cluster condition,
one would like to increase the number of clusters and persons minimizing this cost function. In
Appendix C it is shown that repairing the efficiency loss by multiplying the number of clusters
and the number of persons in the control condition by a factor 1/RE is not cost-optimal. However,
this rule turns out to be almost cost-effective, and therefore is recommended as a simple rule for
regaining the efficiency.
When on the other hand, interest focuses on estimating the random intercept variance, only the
number of clusters in the cluster condition needs to be multiplied by 1/RE, since the variance
of this estimator only depends on the data of this condition (see equations (B1) and (B2) in
Appendix B).
We illustrate the application of these results for a clinical trial by Haugli et al. [8], which
involves patients with chronic musculoskeletal pain. One group received usual treatment on an
individual basis: medication, occasionally supplemented by physiotherapy. The other condition was
usual treatment supplemented by a learning program. The learning program consisted of receiving
counseling from specially trained health personnel in group sessions. For testing the treatment
effect, Moerbeek and Wong [18] provide formulas to calculate the number of groups in the cluster
condition, given a fixed and equal group size, as well as the number of persons in the control
condition. Taking the estimates from the study of Haugli et al. [8] as best guesses as to the true
values of the parameters, these formulas can be used to calculate the sample size in case one
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would like to replicate this study. Starting from clusters of size n=8, a power of 80 per cent, a
type I error probability of 5 per cent, nK+1=102 subjects are needed for the control condition,
and K =15 therapy groups are needed for the cluster condition (for details, see [18]).
The present simulation results show that unequal cluster sizes lead to loss of efficiency when
estimating the treatment effect 1. Since the cluster size distribution is unknown, one may start
from a pessimistic scenario assuming a bimodal distribution with, say, ga =3,gb=8 and gc=13,
and fa = fc=6 and fb=3, implying that CV=0.56. Assuming furthermore pessimistic choices
for (=0.5) and for the allocation ratio (=4), the present study suggests that the RE may become
as low as 0.90 (see Table III). This loss can be restored in a (near) cost-optimal way by multiplying
both the number of groups in the cluster condition and the number of subjects in the other condition
1/RE= 10.90 =1.11 times, yielding K =17 and nK+1=113.
Repairing the efficiency loss for the random intercept variance 20 requires only increasing
the number of clusters in the cluster condition. For the same pessimistic scenario, the minimum
RE=0.84 (see Table III), implying that the number of clusters has to be multiplied by 10.84 =1.19.
This results in K =18 groups of size 8, which still is a modest extension of the original design.
6. CONCLUSIONS AND DISCUSSION
When analyzing data from trials in which treatments have clustering effects, care has to be taken
of the dependency between observations within clusters. In case the outcomes within each of the
treatment arms are (approximately) normally distributed, linear mixed models provide a useful
tool for capturing this clustering. When comparing group therapy with pharmacological treatment
or with no treatment at all, or when comparing an individual treatment condition where therapists
each treat several patients with a waiting-list condition, clustering may occur in only one of two
treatment arms. For these designs Moerbeek and Wong [18] derived formulas for calculating the
sample size when testing the treatment effect. In planning such a trial one should, however, also
consider the loss of efficiency due to varying cluster sizes. This loss was studied by deriving
expressions for the asymptotic RE of unequal versus equal cluster sizes. The extent to which these
asymptotic results hold for realistic sample sizes was studied through an extensive Monte Carlo
simulation.
The asymptotic RE described the simulated RE for the treatment effect rather adequately.
For the random intercept variance, the simulated RE was clearly lower than the asymptotic RE.
This was especially true for REML estimation. For the treatment effect the asymptotic results
can be used in calculating the efficiency loss, for the intercept variance the simulated relative
efficiencies as obtained in this study can be used.
The simulated RE clearly depends on the shape of the cluster size distribution, but also on the
variation of cluster sizes. The bimodal distribution and largest CV yield the lowest REs for both
efficiency criteria considered. In addition, for the estimator of the treatment effect the simulated
RE depends on the ratio of error variances and on the allocation ratio, in a way that is predicted
by the asymptotic expression for the RE. There were hardly any differences between ML and
REML in the RE of the treatment effect estimator. For the RE of the intercept variance, there was
a consistent advantage of the ML estimator over the REML estimator. Then for estimating 20, ML
appears to be somewhat more robust than REML against varying cluster sizes.
As was illustrated by the simulated REs, the loss of efficiency was modest. This was in line with
the asymptotic relative efficiencies being larger than those for cluster randomized trials [24, 26].
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The RE of unequal versus equal cluster sizes for the treatment effect estimator exceeds 0.90.
It was shown that the almost cost-efficient way of restoring the efficiency level to the level of
efficiency of designs with equal cluster sizes was by increasing the number of clusters and the
number of persons in the control condition both by (1/RE)−1, which in practice probably is 11
per cent at most. For the intercept variance estimator, the RE could be as low as 0.84, which can
be compensated by only increasing the number of clusters in the cluster condition by (1/RE)−1,
thus by 19 per cent at most. However, note that the exact losses depend on the type of cluster size
distribution and on the CV of the cluster sizes. In many cases, the loss of efficiency will be less
than the maximum losses found in this study.
Other cluster size distributions involving more than 3 cluster sizes and also involving larger
numbers of clusters (K =15 and K =16), as well as models involving other values for the param-
eters were examined. The results for these examples were in line with the results as obtained in
the present Monte Carlo simulation study, thereby supporting the generalizability of the results.
In many intervention studies a binary outcome measure is used. A useful extension of the
present study would therefore involve the logistic mixed effects model. It has to be examined
whether (approximate) formulas for the asymptotic RE can be derived. These formulas, similar to
the present study, could then be tested for their practical utility through a Monte Carlo simulation
study.
APPENDIX A: DERIVATION OF THE RE FOR THE ML ESTIMATOR
OF THE TREATMENT EFFECT
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Let bT=(0,1) and 1 a vector of n j ones. In matrix notation, the analysis model (see
equation (1)) for the scores of cluster j =1, . . . ,K can be formulated as
y j =X jb+1u0 j +e j (A1)
and for cluster K +1 we have:
yK+1=XK+1b+dK+1 (A2)
Let I denote the identity matrix and J a matrix with only ones. The variance–covariance matrix
of the scores for cluster j =1, . . . ,K can be derived as:
V j =2εI+20J (A3)
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Let we=n/(n20+2ε), with n the average cluster size in the cluster condition. The relative


























Employing the Jensen inequality (see e.g. [23, p.72]), it can be seen that the right part between
parentheses in equation (A9) is larger than 1. Since the left part between parentheses is the RE
for ̂1 for cluster randomized trials [24], this implies that RE(̂1) in case of trials with clustering
in one of the treatment arms is larger.
APPENDIX B: DERIVATION OF THE RE FOR THE ML ESTIMATOR OF THE
RANDOM INTERCEPT VARIANCE
The variance components of the cluster and the control condition are estimated for separate parts
of the sample, and their estimators are therefore independent. The asymptotic variance–covariance
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The asymptotic RE for the random intercept variance can be derived from equations (B1) and





































APPENDIX C: OPTIMAL RESTORATION OF THE EFFICIENCY LOSS DUE TO VARYING
CLUSTER SIZES IN CASE OF THE TREATMENT EFFECT ESTIMATOR
Let RE denote the relative efficiency of unequal versus equal cluster sizes. Let f1 and f2 denote
the multiplication factors of the number of persons in the control condition and the number of
clusters in the other condition, respectively. To restore the efficiency loss, equation (A8) shows












This constraint can be rewritten as:
f2= 
RE×(+)−/ f1 (C2)
The cost function that has to be minimized then becomes:
f1nK+1ci + f2Kc∗c = f1nK+1ci +Kc∗c/(RE×(+)−/ f1) (C3)














When the number of persons in the control condition and the number of clusters are chosen under
the same cost function as in equation (5), then according to [18, p.2854], we have (nK+1/K )2=

























Substituting this result in equation (C4), we obtain, after some rewriting:
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Solving for f1 yields two solutions, one of which minimizes the cost function in equation (C3)


















As can be seen, if we have equal cluster sizes, then RE =
√∑
w j/(Kwe)=1 and thus f1=
f2=1, since no repair is needed. In addition note that f1/ f2=
√∑
w j/(Kwe), showing that, since√∑
w j/(Kwe)<1, relatively more clusters should be added to the cluster condition than persons
to the control condition. A problem with the cost-minimizing factors in equation (C7) is that they
require knowledge on =1/∑Kj=1w j and =2/nK+1, and also on √∑w j/(Kwe), which often
will not be available. However, although choosing f1= f2=1/RE is not optimal for regaining the
efficiency, it can be shown to be highly efficient with costs differing from the costs for the optimal
factors by less than 1 per cent in almost all cases.‡
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